RBC Raises PTC Therapeutics Price Target to $77 From $75
RBC raised its price target on PTC Therapeutics to $77 from $75 and kept its Sector Perform rating.
RBC raised its price target on PTC Therapeutics to $77 from $75 and kept its Sector Perform rating.